Your browser doesn't support javascript.
loading
Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma).
Waldschmidt, Johannes M; Keller, Alexander; Ihorst, Gabriele; Grishina, Olga; Müller, Stefan; Wider, Dagmar; Frey, Anna V; King, Kristina; Simon, Roman; May, Annette; Tassone, Pierfrancesco; Duyster, Justus; Jung, Manfred; Raje, Noopur; Wäsch, Ralph; Engelhardt, Monika.
  • Waldschmidt JM; Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany.
  • Keller A; Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, University of Freiburg, Germany.
  • Ihorst G; Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany.
  • Grishina O; Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, University of Freiburg, Germany.
  • Müller S; Clinical Trials Unit, Faculty of Medicine, University of Freiburg, Germany.
  • Wider D; Clinical Trials Unit, Faculty of Medicine, University of Freiburg, Germany.
  • Frey AV; Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany.
  • King K; Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany.
  • Simon R; Institute of Pathology, Faculty of Medicine, University of Freiburg, Germany.
  • May A; Institute of Pharmaceutical Sciences, Faculty of Medicine, University of Freiburg, Germany.
  • Tassone P; Institute of Pharmaceutical Sciences, Faculty of Medicine, University of Freiburg, Germany.
  • Duyster J; Institute of Pathology, Faculty of Medicine, University of Freiburg, Germany.
  • Jung M; Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
  • Raje N; Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany.
  • Wäsch R; Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, University of Freiburg, Germany.
  • Engelhardt M; Institute of Pharmaceutical Sciences, Faculty of Medicine, University of Freiburg, Germany.
Haematologica ; 103(10): e473-e479, 2018 10.
Article en En | MEDLINE | ID: mdl-29674494
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article